deltatrials
Recruiting PHASE1 INTERVENTIONAL 3-arm NCT07217379

The DART DELIVER-02 Study (DELIVER-02)

IGHID 12430 - Deliver-02 - A Phase 1, Open Label, Randomized Study To Evaluate The Safety And Tolerability Of MGD014 And MGD020 With A Latency Reversal Agent Versus Temporary Treatment Interruption In Persons With HIV-1 On Antiretroviral Therapy

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Conditions HIV (Human Immunodeficiency Virus)
Interventions MGD014 MGD020 Temporary treatment interruption Vorinostat
Updated 2 times since 2025 Last updated: Dec 8, 2025 Started: Oct 2, 2025 Primary completion: Dec 31, 2026 Completion: Feb 28, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates HIV (Human Immunodeficiency Virus) and is currently actively recruiting participants. Henry M. Jackson Foundation for the Advancement of Military Medicine leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Nov 2025 – ~Jan 2026 · 2 months · monthly snapshotRecruiting~Jan 2026 – present · 5 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Jan 2026 — Present [monthly]

    Recruiting PHASE1

  2. Nov 2025 — Jan 2026 [monthly]

    Recruiting PHASE1

    First recorded

Oct 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Henry M. Jackson Foundation for the Advancement of Military Medicine
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • US Military HIV Research Program
  • United States Department of Defense
  • University of North Carolina, Chapel Hill
Data source: University of North Carolina, Chapel Hill

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations